These benefits, together with a former report exhibiting that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like habits in mice,2 assist the concept of targeting ACKR3 as a novel strategy to modulate the opioid program, which could open up new therapeutic avenues for opioid-related Diseases.Morphine together with other opioids raise th